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a b s t r a c t
The epicardium and coronary vessels originate from progenitor cells in the proepicardium. Here we show
that Tbx18, a T-box family member highly expressed in the proepicardium, controls critical early steps in
coronary development. In Tbx18/ mouse embryos, both the epicardium and coronary vessels exhibit
structural and functional defects. At E12.5, the Tbx18-deﬁcient epicardium contains protrusions and cyst-
like structures overlying a disorganized coronary vascular plexus that contains ectopic structures
resembling blood islands. At E13.5, the left and right coronary stems form correctly in mutant hearts.
However, analysis of PECAM-1 whole mount immunostaining, distribution of SM22αlacZ/þ activity, and
analysis of coronary vascular casts suggest that defective vascular plexus remodeling produces a
compromised arterial network at birth consisting of fewer distributing conduit arteries with smaller
lumens and a reduced capacity to conduct blood ﬂow. Gene expression proﬁles of Tbx18 / hearts at
E12.5 reveal altered expression of 79 genes that are associated with development of the vascular system
including sonic hedgehog signaling components patched and smoothened, VEGF-A, angiopoietin-1,
endoglin, and Wnt factors compared to wild type hearts. Thus, formation of coronary vasculature is
responsive to Tbx18-dependent gene targets in the epicardium, and a poorly structured network of
coronary conduit vessels is formed in Tbx18 null hearts due to defects in epicardial cell signaling and fate
during heart development. Lastly, we demonstrate that Tbx18 possesses a SRF/CArG box dependent
repressor activity capable of inhibiting progenitor cell differentiation into smooth muscle cells,
suggesting a potential function of Tbx18 in maintaining the progenitor status of epicardial-derived cells.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Lineage mapping and genetic analysis studies have shown that
proepicardial (PE) cells are progenitors for the epicardium, cor-
onary smooth muscle cells (CoSMCs), perivascular and intermyo-
cardial ﬁbroblasts, and a subpopulation of cardiac myocytes
(Mikawa and Fishman, 1992; Gittenberger-de Groot et al., 1998;
von Gise and Pu, 2012; Zhou et al., 2008). In the mouse, the PE ﬁrst
appears around E8.5 on the surface of septum transversum
mesenchyme near the sinoatrial junction (Viragh and Challice,
1981). PE cells reach the heart between E9.5 and E10.5, attach to
the myocardium and migrate over it to produce a continuous sheet
of mesothelial cells that forms the epicardium (Manner, 1992;
Sengbusch et al., 2002). Coronary vessel development depends
upon epicardial cells that undergo an epithelial to mesenchymal
transition (EMT), followed by vasculogenesis in the subepicardial
space, formation and remodeling of a capillary-like vascular
plexus, and eventual recruitment of CoSMCs (Majesky, 2004;
Olivery and Svensson, 2012). Development of a subepicardial
coronary plexus occurs between E11.5 and E13.5 in the mouse,
and is followed by formation of left and right coronary stems in
the aortic valve sinuses. Unlike the systemic vasculature, which
develops gradually along with formation of the heart, when the
coronary plexus makes contact with the aortic lumen at E13.5, it
establishes continuity with an already functional circulation.
Therefore, formation of an optimal network of coronary arteries,
veins and capillaries to ensure efﬁcient perfusion in mature hearts
requires a preformed vascular plexus in the subepicardium that is
already well organized to receive blood ﬂow from the aorta
at E13.5.
T-box 18 (Tbx18) is a member of the T-box transcription factor
family (Kraus et al., 2001; Naiche et al., 2005). Loss of function
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/developmentalbiology
Developmental Biology
0012-1606/$ - see front matter & 2013 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.ydbio.2013.08.019
n Corresponding author. Fax: þ1 713 790 1275.
nn Corresponding author.
E-mail addresses: sanpinw@bcm.edu (S.-P. Wu), mwm84@uw.edu
(M.W. Majesky).
1 Fax: þ1 206 884 1407.
Developmental Biology 383 (2013) 307–320
studies show that Tbx1, Tbx2, Tbx3, Tbx5, and Tbx20 play critical
roles in cardiac development (Greulich et al., 2011). Expression of
Tbx18 is ﬁrst detected in presomitic mesoderm and cranial paraxial
mesoderm, in E7.75 mouse embryos (Kraus et al., 2001; Bussen
et al., 2004). Later, Tbx18 is strongly expressed in the PE, epicar-
dium, epicardial-derived cells (EPDC) in subepicardial mesench-
yme, septum transversum, somites, limb buds, aorta-gonad-
mesonephros region and a subset of myocardium (Bussen et al.,
2004; Airik et al., 2006; Christoffels et al., 2009; Christoffels et al.,
2006). Analysis of Tbx18-expressing cell fates in the mouse heart
showed that epicardial cells, CoSMCs, atrioventricular valve inter-
stitial cells, and a subpopulation of cardiac myocytes derive from
Tbx18-positive progenitor cells (Cai et al., 2008; Christoffels et al.,
2009; Mommersteeg et al., 2010). Loss of Tbx18 function causes
perinatal lethality with defects in skeletal, urogenital systems and
pleuropericardial membranes, and with concomitant disruptions
of Notch, Wnt and Hedgehog signaling pathways (Bussen et al.,
2004; Airik et al., 2006; Norden et al., 2012).
In the developing heart, Tbx18 deﬁciency results in dysmorpho-
genesis of the sinus node (Wiese et al., 2009), while forced over-
expression of Tbx18 reprograms ventricular myocytes to pace-
maker cells in rodents (Kapoor et al., 2012). Because Tbx18 is
highly expressed in the PE and epicardium, we sought to deter-
mine its role in coronary vessel formation during heart develop-
ment. We found that Tbx18-deﬁcient PE produces an epicardium
and coronary vasculature with structural and functional defects
and that remodeling of the disorganized subepicardial plexus in
Tbx18-deﬁcient hearts produced a mature coronary artery network
with fewer distributing conduit vessels and smaller lumen proﬁles
than that of wild type hearts.
Materials and methods
Generation of Tbx18 mutant mice
The Tbx18tm1mwm allele was generated by replacing exon 1
sequences encoding the predicted translation initiation site and
the N-terminal domain of the protein, and exon 2 sequences
encoding the amino-terminal residues of the highly conserved
T-box, with an IRES-nlacZ reporter as depicted in Fig. S1. All mice
were maintained in a 129/C57BL6/J mixed background.
Histological analysis and immunoﬂuorescence staining
Histological analysis was performed by using standard procedures
(Landerholm et al., 1999).
Skeletal preparation
The skeletal preparation procedure was adopted from Mcleod
(1980).
Whole mount ß-galactosidase activity
Embryos or tissues were whole mount-stained for ß-galactosi-
dase activity as previously described (Passman et al., 2008).
Scanning electron microscopy (SEM)
Freshly harvested hearts were ﬁxed in 2% PFA/2.5% glutaralde-
hyde in 0.15M Karlsson and Schultz solution at 4 1C overnight,
postﬁxed in 1% buffered osmium tetroxide, dehydrated, critical
point dried, sputter coated with a 60/40 Au/Pd alloy and examined
on a Cambridge S-200 scanning electron microscope as described
(Dong et al., 2008).
Whole mount immunoﬂuorescence and confocal microscopy
Dissected hearts were placed in ice-cold PBS, ﬁxed and per-
meabilized in methanol/DMSO (4:1) overnight at 4 1C, bleached in
methanol/DMSO/H2O2 (4:1:1) for 4 h at room temperature, and
preserved in methanol at 20 1C. Tissues were prepared, stained,
and imaged by confocal microscopy as previously described
(Passman et al., 2008; Dong et al., 2008).
Cell proliferation and apoptosis assays
Cell proliferation was assessed in whole mount or tissue
sections using anti-phosphohistone-H3 antibody. Apoptosis was
determined by TUNEL assay using the ApopTag Fluoroscein in situ
Apoptosis Detection kit (Chemicon, Inc) according to the manufac-
turer's instructions.
Coronary vascular casts
Vascular casts were prepared as described (Adamson et al.,
2002). Coronary casts were mounted on an SEM stub, with the
apex of the ventricles oriented upward, and visualized by scanning
electron microscopy (SEM).
Microarray analysis
Generation of labeled antisense RNA for microarray: total RNA
was extracted from four pooled Tbx18-null hearts and three
pooled wild type E12.5 hearts (ToTally RNA kit, Ambion, Inc.),
and underwent one round of linear ampliﬁcation (Amino Allyl
MessageAmpII kit, Ambion, Inc.). The paired antisense RNA sam-
ples were hybridized to glass microarrays containing the Operon
Mouse Aros 4.0 Oligo library (oligomers spotted by the Microarray
Core Facility, Department of Systems Biology & Translational
Medicine, Texas A&M University). After imaging, the acquired data
were transformed, normalized and ﬁltered using the GeneSpring
v7.0 software package (Silicon Genetics, Agilent Technologies).
Gene expression signiﬁcance was assessed using multiple t-tests
(po0.05) and the Benjamini–Hochberg false discovery rate multi-
ple testing correction. Molecular function and pathway analysis
was performed via Ingenuity Pathway Analysis.
Real-time quantitative RT-PCR analysis
cDNA was generated by M-MLV Reverse Transcriptase (Invitro-
gen) followed by Taqman real time PCR analysis on an ABI-7700
thermal cycler according to the manufacturer's instructions. Data
were analyzed by the ΔΔCT method.
Transient transfection and reporter assays
COS7 and C3H10T1/2 cells were cultured in 24-well tissue
culture plates at a starting density of 5104 cells/well in DMEM
supplemented with 10% fetal bovine serum and transfected with
FuGENE6 (Roche) per the manufacturer's instructions. For reporter
assays, the amount per well of plasmid DNA was kept constant at
50 ng for luciferase constructs, 50 ng for SRF and 5 ng for myo-
cardin, while titering in Tbx18 (50–200 ng) or complimentary
amounts of empty vector DNA to reach a constant 300 ng total
amount of these two plasmid DNAs. Each well was co-transfected
with pGL4-SV40-Renilla luciferase-reporter (Promega, with a con-
stant ratio of Fireﬂy luciferase-reporter: Renilla luciferase-
reporter¼50:1) for normalization. Luciferase assays were per-
formed using a commercially available substrate kit (Promega).
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Materials
Antibodies used in this study include anti-PECAM-1 (BD Phar-
mingen, #550274, 1:100), anti-phosphohistone H3 (Upstate, 1:100),
anti-Wilms’ Tumor-1 (Santa Cruz, 1:100), anti-cytokeratin (Dako,
1:100), anti-SMγActin (Seven Hills Bioreagents,1:500), anti-SM22α
(Abcam, 1: 500), anti-COUP-TFII antibody (R&D Systems, 1:2000) and
anti-V5 (Invitrogen, 1: 800). Nuclei counterstaining was performed
with SYTOX Green, TOPRO-3 or Hoechst 33258 (Invitrogen). Tie2GFP/þ
reporter mice (Tg(TIE2GFP)287Sato) were obtained from The Jackson
Laboratory. SM22αLacZ/þ reporter mice (SM22TMlili) were a generous
gift of Dr. Li Li (Wayne State University). The Tbx18 expression
vector was generated by cloning the cDNA fragments encoding full-
length murine Tbx18 (accession number AF306666) into V5-tagged
myo
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Fig. 1. Expression of Tbx18 nLacZ. Tbx18 expression was detected by β-galactosidase activity from an nLacZ reporter gene introduced into the Tbx18 locus. (A) and (B) Tbx18
expression in the proepicardium (pe), septum transversum (stm), and aorta-gonad-mesonephros (agm) region in E9.5 Tbx18 / embryos. Note that the PE has begun to
invest epicardial cells onto the surface of the heart (h) (arrow). (C) and (D) At E12.5, expression of Tbx18 is found in the epicardial layer ((h), panel (C)), and in the
subepicardial mesenchyme (arrowheads, panel D). (E) and (F) Tbx18 is selectively expressed in the epicardium (epi) at E18.5. a; atrium, v; ventricle, lv; liver, cv; coronary
vessel, epi; epicardium, myo; myocardium.
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Fig. 2. Defects in coronary vessel formation in Tbx18 / hearts. (A) and (B) Histology of the left ventricular free wall at E18.5 (H&E stain). Note large diameter subepicardial
coronary vessels are evident in wild type, but not in Tbx18 / mutant hearts. Also note that the ventricular wall of Tbx18 / hearts is not abnormally thin. (C) and (D) The
Tbx18tm1mwm allele was crossed into a Tie2-GFP reporter background. Capillary vessel density in Tbx18 / hearts at E18.5 was not obviously different from wild type. (E) The
structure of major coronary conduit arteries was examined by crossing the Tbx18tm1mwm allele into an SM22αlacZ/þ reporter background. Three representative hearts
(arranged vertically) from P0 pups of the indicated genotype were stained for ß-galactosidase activity and photographed to show the left coronary artery (LCA) and its major
branches. Signiﬁcant reductions in overall length and branching complexity of the LCA were found in Tbx18 / hearts.
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pcDNA3.1 expression vector (pcDNA3.1/V5-His-TOPO, Invitrogen).
Expression plasmids encoding SRF.HA and myocardin cloned into
pcDNA3 as well as the 447 bp mouse SM22α promoter-luciferase
and the 356 bp c-fos promoter-luciferase reporters were kind gifts
from Dr. Da-Zhi Wang (Boston Children's Hospital). Constructs
encoding 1224, 176, 65 bp chick smooth muscle γ-Actin
(SMγA) promoter cloned in front of a pGL-3 luciferase reporter gene
were generously provided by Dr. Warren Zimmer (Texas A&M
University) (Carson et al., 2000).
Results
Tbx18-deﬁciency is perinatal lethal
Tbx18þ / mice were viable and fertile, and exhibited no
obvious defects in morphology, growth or behavior. Newborn
Tbx18 / mice had difﬁculty breathing and died within 24 h after
birth. Mendelian ratios of expected genotypes were found in
embryos up to E18.5, conﬁrming a perinatal lethal phenotype.
Although the Tbx18 targeting construct used by Bussen et al.
(2004) deleted a shorter segment of the Tbx18 locus than our
mutant allele (Fig. S1), our mice have essentially identical defects
in the axial skeleton (Fig. S2) and kidney–ureter (not shown) as
described by their group (Bussen et al., 2004; Airik et al., 2006). In
this study, we focus on phenotypes not previously reported for
Tbx18-deﬁcient mice.
Expression of Tbx18-nlacZ during development of the epicardium
The nLacZ reporter gene in the targeted allele faithfully
reﬂected expression of the endogenous Tbx18 gene in the devel-
oping proepicardium (PE), epicardium, septum transversum and
AGM (aorta-gonad-mesonephros) region (Fig. 1A–D) (Kraus et al.,
2001). The epicardial layer is uniformly positive as it covers the
heart (Fig. 1C–F, S3B). Moreover, LacZ-positive cells can be
detected in the subepicardial mesenchyme at E12.5 (arrowheads,
Fig. 1D), but much less frequently in deeper layers of the myo-
cardial wall. Expression of Tbx18 in the sinus horns, and caval veins
has been described (Christoffels et al., 2006). We failed to detect
Tbx18nlacZ/þ expression in coronary endothelium or smooth
muscle (Fig. 1F, S3B). Other tissues that are marked by the
Tbx18nlacZ/þ reporter include limbs, mesothelium and whisker
primoridium (Fig. 1C and S3A).
Analysis of coronary vasculature in Tbx18-deﬁcient hearts at E18.5
Histological analysis of Tbx18-deﬁcient hearts at E18.5 revealed
fewer large diameter coronary vessels in the subepicardium and
ventricular septum compared to wild type hearts (Fig. 2A and B).
To gain insight into the basis for this difference in coronary
proﬁles, we bred the Tbx18 mutant allele into two different
Fig. 3. Defects in epicardium at E12.5 in Tbx18 / hearts. (A) and (B) Gross view of
epicardium at E12.5. A translucent epicardial layer (yellow arrowheads) forms a
uniform covering in wild type hearts, and a more irregular and blistered surface in
Tbx18 / hearts. (C) and (D) H&E staining of cross-sections of ventricular free wall
at E12.5 shows a smooth surfaced epicardium (red dotted line), and a subepicardial
space of uniform thickness in wild type hearts, and an irregular epicardium with a
subepicardial space of variable thickness in Tbx18 / hearts. (E) and (F) Low
magniﬁcation images of PECAM-1 whole mount stains reveal numerous ectopic
nodules (arrows, panel F) of PECAM-1-positive cells (PECAM1pos, red) in Tbx18 /
ventricles (E12.5) (nuclei stained green). A small number of these PECAM-1pos
nodules are normally found in the atrioventricular sulcus of wild type hearts
(arrow, panel E). (G) H&E stained section of E12.5 heart showing that subepicardial
nodules contain erythroblasts (arrow) or mesenchymal cells (arrowhead) in
Tbx18 / heart. (H) High power view of (F) showing PECAM-1pos clusters (red) in
the subepicardium (arrow) (nuclei, green). (I) PECAM-1pos nodules were counted
from different regions of wild type (WT, blue cylinders, n¼4) and Tbx18-deﬁcient
(KO, red cylinders, n¼5) hearts at E12.5. vLV and dLV; ventral and dorsal surface of
left ventricle, vRV and dRV; ventral and dorsal surface of right ventricle, vIVS and
dIVS; ventral and dorsal surface of interventricular sulcus.
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cell type-speciﬁc reporter backgrounds. Tie2þ /GFP reporter mice
express green ﬂuorescent protein (GFP) in an endothelial cell-
speciﬁc pattern throughout development (Motoike et al., 2000).
By confocal microscopy, no obvious differences in number or
organization of microvascular endothelial cells within the ventri-
cular walls were found in wild type and Tbx18-deﬁcient
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hearts (Fig. 2C and D). Signiﬁcant differences were found, however,
when Tbx18-mutant hearts were examined on an SM22αþ /lacZ
CoSMC reporter background (Yang and Li, 2010). For this analysis,
hearts were examined between 0 and 24 h after birth so as to
minimize residual background lacZ signals due to earlier expres-
sion of SM22α by immature cardiac myocytes (Li et al., 1996). Both
wild type and Tbx18þ / hearts exhibited well-developed coronary
arteries invested with SM22α-expressing CoSMCs (Fig. 2E). By
contrast, coronary arteries in Tbx18 / hearts displayed reduced
smooth muscle content and shorter overall smooth muscle cover-
age along the length of coronary arteries at birth (Fig. 2E). In
addition, a less well-developed branching network of subepicar-
dial conduit vessels in mutant hearts was also apparent in the
SM22αþ /lacZ background (Fig. 2E). Morphometric analysis of the
left coronary artery in the SM22αþ /lacZ background showed a
reduced overall diameter of the coronary stems in Tbx18-null
hearts (wild type: 7677 mm; Tbx18 /: 5172 mm), and a reduced
branching index (wild type: 6.572 branch vessels/left coronary
artery; Tbx18 /: 3.772 branch vessels/left coronary artery). To
further investigate this smooth muscle phenotype, we examined
endogenous levels of smooth muscle markers by immunostaining.
In E18.5 hearts, levels of SM22α are comparable between control
and Tbx18 / mice in the portion of coronary stems that lies
between the coronary ostia and the ﬁrst branch of circumﬂex
artery (Fig. S4A and B). This result suggests that, in coronary
smooth muscle cells, SM22α expression does not depend on Tbx18.
Conversely, in the distal part of coronary arteries, Tbx18 /
displays reduced expression of overall SM22α in comparison to
control (Fig. S4C and D), which is consistent with our observation
using the SM22α-LacZ reporter. To determine whether the reduc-
tion of smooth muscle coverage is due to differentiation defects or
reduced numbers of cells, we examined the presence of differ-
entiating smooth muscle cells by staining of COUP-TFII (You et al.,
2005). Our results reveal that, in Tbx18-null mutant, the distal part
of coronary arteries is covered with fewer COUP-TFII-positive
smooth muscle cells in comparison with control (Fig. S4E and F).
Notably, these COUP-TFII-positive smooth muscle cells still express
SM22α despite the reduction in numbers (Fig. S4D), suggesting the
process of smooth muscle differentiation remains functional in the
Tbx18 / background. In summary, our data suggest that deletion
of Tbx18 results in fewer numbers of smooth muscle cells invested
on coronary arteries, which causes reduced smooth muscle con-
tent and overall smooth muscle coverage along the length of
coronary arteries.
Appearance of the epicardium at E12.5
To gain insight into the developmental basis for the altered
coronary network structure in Tbx18 / hearts described above,
we ﬁrst examined the epicardial layer at E12.5, a time point at
which coronary vessels are beginning to form in the subepicar-
dium (Tomanek, 2005). Using low angle illumination, the epicar-
dium of mutant hearts was seen to form a complete, but irregular
covering of the heart with frequent areas that were distended
from the myocardial layer (Fig. 3B) when compared to wild type
hearts (Fig. 3A). Histological analysis conﬁrmed the impression of
a continuous, but irregular epicardial surface (Fig. 3C and D), and
also revealed that the subepicardium of Tbx18 / hearts contained
scattered clusters of densely packed nucleated erythroid cells
covered by a continuous epicardial layer (Fig. 3G, arrow). Compar-
able structures were only rarely encountered in wild type hearts
(Fig. 3E). Despite occasional mutant hearts in which
cystic structures containing erythroid cell pools were found
(Fig. 4B, inset), we did not observe pericardial hemorrhage in
Tbx18-null embryos. When viewed at the level of the epicardial
surface, the spherical clusters caused mound-like protrusions of
the epicardium (Fig. 3H). PECAM-1 (CD31) is a cell surface protein
expressed by platelets, endothelial cells, and erythroid progenitors
(Baldwin et al., 1994; Ema et al., 2006). Quantitation of the number
of PECAM-1-positive spherical clusters in different regions of wild
type and Tbx18-deﬁcient hearts is shown in Fig. 3I. Large increases
in the number of these clusters were conﬁned to the left and right
ventricular free walls of mutant hearts (Fig. 3I).
The irregular appearance of the epicardial surface of Tbx18 /
hearts is more apparent by scanning electron microscopy (Fig. 4A–
D). The epicardium covering the ventricular free walls of Tbx18-
deﬁcient hearts at E12.5 is composed of numerous mound-like
structures and occasional cyst-like protrusions (collapsed in pre-
paration for ScEM) (Fig. 4B), whereas epicardium of wild type
hearts is ﬂattened and more uniform (Fig. 4A). Higher magniﬁca-
tion images show an intact epicardium covering the mound-like
structures in which the continuity of cell-cell junctions between
individual epicardial cells is maintained (Fig. 4C and D). The
irregular-appearing epicardium covering the ventricular free walls
of Tbx18-deﬁcient hearts exhibited reduced rates of cell prolifera-
tion and increased rates of apoptosis when compared to equiva-
lent areas of epicardium in wild-type hearts (Fig. 4E and F). By
contrast, morphologically normal appearing epicardium covering
the inﬂow tract, atrium and atrioventricular canal of Tbx18 /
hearts exhibited rates of cell proliferation and cell death that were
not signiﬁcantly different from equivalent areas of wild type
epicardium (not shown).
Formation of a subepicardial coronary vascular plexus at E12.5
We used PECAM-1 whole mount immunostaining and confocal
microscopy to reconstruct the subepicardial coronary plexus (Fig. 4G–J)
by stacking a Z-series of confocal images from the atrio-ventricular
canal (lower right) to the apex of the left ventricle (dotted line, upper
left). At E12.5, coronary vasculogenesis in wild type hearts is nearly
complete, but the coronary stems have not yet formed connections to
the aorta and there is no coronary blood ﬂow. In wild type hearts, the
subepicardial coronary plexus covered 80% to 95% of the ventricular
surface area with a regular array of interconnected capillary-like
vessels of uniform diameter (Fig. 4G). In Tbx18-mutant hearts, the
ventricular surface area coverage (50% to 75%) was reduced (dashed
line), and an irregular network of variably sized tubular structures that
made fewer connections within the network was present (Fig. 4H–J).
In addition, occasional nodular clusters of PECAM1-positive cells seen
in the wild-type hearts (Fig. 3E and Fig. 4G, arrows) were greatly
Fig. 4. Epicardial surface of Tbx18 / hearts. (A)–(D) Scanning electron microscopy (ScEM) of E12.5 hearts. (A) and (B) Anterior view of hearts with apex of ventricles
positioned upward. In contrast to the smooth appearance of epicardium covering wild type hearts (A), numerous mound-like protrusions and occasional cyst-like structures
(collapsed in B) were found in mutant epicardium (B). Inset in (B) shows a blood-ﬁlled cyst on right ventricle prior to specimen preparation for ScEM. (C) and (D) High power
view of left ventricle of (A) and (B) respectively. (E) and (F) Analysis of cell proliferation (E), and cell death (F) in epicardium that covers ventricular free walls (see panels
(A) and (B)). Mean values7standard deviations are shown for wild type (blue triangles) and Tbx18-deﬁcient (red circles) epicardial cells. Asterisks indicate signiﬁcant
differences in wild type versus mutant epicardium (po0.05). (G)–(J) Stacked Z-plane confocal images of E12.5 hearts stained for PECAM-1 (red) with apex of heart oriented
toward top left, and atrioventricular canal at lower right. (G) A representative wild type heart showing a normal subepicardial vascular plexus covering 90% of the left
ventricle. Dotted line outlines the ventricle, dashed line marks the extent of capillary plexus coverage (arrow indicates blood island-like cluster). (H)–(J) Tbx18-deﬁcient
hearts fail to develop a normal coronary plexus. Note that newly formed vessels are disorganized with fewer interconnections and more variable diameters in mutant hearts.
The extent of myocardial coverage (dashed lines) is much less than in wild type hearts, and many more PECAM-1pos nodules (arrows) are found scattered over the ventricular
surface. Dense collections of unorganized PECAM-1pos cells (panel J, asterisk) were also occasionally found in Tbx18/ hearts.
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increased in number and scattered ectopically throughout the sub-
epicardium in Tbx18 / hearts (Fig. 3F and Fig. 4G–J, arrows). In some
cases, loose aggregates of PECAM-1-positive cells that had not incor-
porated into the tubular network were found among the tightly
packed nodular clusters (Fig. 4J, asterisk).
Coronary plexus remodeling after initiation of blood ﬂow at E13.5
A coronary vascular plexus that forms around the aortic root
connects with the aortic lumen and establishes directional blood ﬂow
through the coronary vasculature at E13.5 in the mouse (Tomanek,
2005). At E14.5, one day after establishment of coronary blood ﬂow,
two main coronary stems had formed in the correct locations in both
wild type and Tbx18-deﬁcient hearts (Fig. 5A and B). In addition,
vascular channels had begun to form in wild-type hearts in positions
where the left coronary artery would later be found in mature hearts
(Fig. 5C, dashed lines). By contrast, it was difﬁcult to identify early
coronary channels in the disorganized vascular plexus that forms in
Tbx18/ hearts at E14.5 (Fig. 5D). Differences in coronary vessel
remodeling between wild type and Tbx18 / hearts continued to be
evident in PECAM-1-stained hearts at E16.5 (Fig. 5E and F).
Analysis of artery–vein identity
To address the possibility that defects in coronary plexus
remodeling might result from a loss of arterial-venous identity
of coronary endothelium in Tbx18 / hearts, we examined the
expression of COUP-TFII, a key transcriptional regulator of venous
identity (You et al., 2005; Chen et al., 2012). When endothelial
cells from either wild type or Tbx18þ / embryos at E18.5 were
examined for COUP-TFII expression, we found clear differences
between arterial (negative) and venous (positive) endothelium
consistent with previous reports (You et al., 2005; van den Akker
et al., 2008) (Fig. S5A and B). Upon examination of multiple
Tbx18 / hearts, we found no evidence for misexpression of
COUP-TFII in coronary arterial endothelial cells (Fig. S5C–F). We
conclude that arterial-venous speciﬁcation of coronary endothelial
cells is not disrupted in Tbx18-deﬁcient hearts.
Analysis of coronary vascular casts by scanning electron microscopy
To directly examine the structure of the coronary vascular
network we employed vascular casting on E18.5 embryos. In
Tbx18þ /þ hearts, the left coronary artery gives off ﬁrst order
branch vessels of more or less uniform diameter at regular
intervals that extend long distances along the surface of the heart
to efﬁciently distribute blood ﬂow to all regions of the left
ventricular myocardium (Fig. 6A). The casts of these ﬁrst order-
distributing arteries describe a vascular pattern that matches well
with the histological cross-sectional proﬁles of subepicardial
vessels (Fig. 2A). In Tbx18 / hearts, fewer ﬁrst order vessels are
found branching off the main left coronary artery (Fig. 6B–D). Also,
the lumen diameter of ﬁrst order branches in mutant hearts is
signiﬁcantly reduced (Fig. 6E and F). When normalized to the
diameter of the left coronary artery directly upstream of the
branch point, the lumen diameter ratios of ﬁrst order distributing
arteries are 0.5170.18 for wild type (n¼8 hearts, 74 branch
points), and 0.3970.21 for Tbx18 / hearts (n¼6 hearts, 58
branch points) (p¼5.89104) (Fig. 6G). Moreover, the overall
length of ﬁrst order distributing arteries before encountering
secondary branches is also reduced in mutant hearts, resulting in
fewer large diameter subepicardial distributing vessels appearing
in histological sections (Fig. 2B). The average calculated maximal
ﬂow rates using Poiseuille's law for the Tbx18 / left descending
coronary artery and its ﬁrst order branch arteries is only 34% of
that for wild type coronary vessels at E18.5. These results conﬁrm
and extend the observations of coronary network defects obtained
when the hearts of Tbx18 mutant mice were examined histologi-
cally (Fig. 2A and B), or in an SM22α-LacZ reporter background
(Fig. 2E).
Gene expression proﬁling in Tbx18 / hearts
To gain insight into the molecular basis for the coronary develop-
mental defects in Tbx18 / hearts at E12.5, we carried out genome-
wide gene expression proﬁling on whole hearts by microarray
analysis. Tbx18 deﬁciency altered expression of 774 genes with
changes greater than 1.5 folds (Table S1). Among them, Ingenuity
Pathway Analysis identiﬁed 71 genes in associationwith development
of vascular system (Fig. 7A and Table S2). Compared with wild type,
Tbx18 / hearts exhibited reduced expression of multiple genes that
have been shown to promote endothelial sprouting, tubular branch-
ing and capillary formation, including Vegfa (VEGF-A) (Gerhardt et al.,
2003), Lama4 (Gonzales et al., 2001), Angptl2 (Kim et al., 1999), Nos3
(Lee et al., 2003), Ctbp2 (Roukens et al., 2010) and Meis1 (Hisa et al.,
2004). Differential gene expression proﬁles were further indepen-
dently investigated by quantitative real-time RT-PCR (qRT-PCR) using
separately prepared pools of E12.5 heart RNA, distinct from those
used for the microarray study (Table S3). Analyses from microarray
and qRT-PCR together demonstrated that loss of Tbx18 expression in
mutant hearts resulted in signiﬁcantly reduced levels of Vegfa, Angpt1
(Angiopoietin-1), and endoglin transcripts, and signiﬁcantly increased
levels of Vegfd (VEGF-D) and Angpt2 (Angiopoietin-2) gene expression
(Fig. 7A and Table S2 and S3). Expression levels of Vegfb (VEGF-B) and
Vegfc (VEGF-C) were not signiﬁcantly different between genotypes.
Strong down regulation of critical hedgehog signaling components
Ptch1 (patched-1), Smo (smoothened), and Gli2 was also found in
Tbx18 / hearts (Table S3 and Fig. 7A). In addition, an expression
proﬁle consistent with down regulation of Wnt signaling (reduced
levels of Wnt4, Wnt5a, Ccnd1, Ppp2r1b and Cskn1e and increased
expression of the soluble inhibitor Sfrp2), and altered TGF-β signaling
was also observed (decreased levels of Tgfb2, Tab1, Inhba and Kras)
(Table S1, S2 and S3). Taken together, the gene expression proﬁle of
Tbx18 / hearts suggests that Tbx18 deﬁciency produces an altered
molecular microenvironment in which disrupted Hedgehog, VEGF,
Angiopoietins, TGF-β and Wnt signaling may cause failure of
forming a well developed subepicardial coronary vascular plexus
(Fig. 7B and C).
The SRF-CArG box dependent repressor activity of Tbx18
Tbx18 possesses strong transcriptional repressor activity via an
engrailed homology-1 motif near the N-terminus that interacts
with Groucho family corepressor proteins (Farin et al., 2007).
To test the possibility that Tbx18 might play a role in maintenance
of a coronary smooth muscle progenitor phenotype in epicardial
cells via its intrinsic transcriptional repressor activity, we trans-
fected COS7 cells with smooth muscle promoter-luciferase repor-
ter constructs in the presence and absence of increasing amounts
of Tbx18 expression vector. We found that Tbx18 inhibits the
activity of smooth muscle cell (SMC) differentiation marker
promoter-luciferase reporters in an SRF-CArG box-dependent
manner (Fig. 8A–D). SMC differentiation marker expression is
greatly increased by interaction of the strong transcriptional
coactivator myocardin with SRF (Wang et al., 2001). Tbx18 also
strongly represses smooth muscle promoter activity stimulated by
a combination of SRF and myocardin (Fig. S6A). Moreover, SRF-
CArG box-dependent transcriptional repression by Tbx18 was also
observed in two other SRF-CArG box-dependent promoters from
the SM22α gene and from the c-fos gene (Fig. S6B and C).
To further test the ability of Tbx18 to inhibit SMC differentiation,
we turned to a commonly used model for SMC differentiation in vitro.
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Fig. 5. Coronary plexus remodeling defects in Tbx18 / hearts. (A) and (B) Stacked Z-plane confocal images of PECAM-1 (red) whole mount staining of E14.5 hearts. Two
coronary stems (dashed yellow lines) form normally in Tbx18 / hearts (B) compared to wild type hearts (A). (C) and (D) Once coronary blood ﬂow is established at E13.5,
vascular remodeling occurs. Continuous, branching channels for blood ﬂow can be identiﬁed in the subepicardium of E14.5 wild type hearts (C, yellow dashed lines), whereas
similar channels are difﬁcult to ﬁnd in Tbx18 / hearts (D). Ventral views of E16.5 (E) and (F) hearts showing signiﬁcant alterations in the pattern, and reductions in length
and diameter (arrow) of the left descending coronary artery in mutant hearts. Note persistence of PECAM-1pos nodules in mutant hearts.
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C3H10T1/2 cells are multipotent mesenchymal progenitor cells that
will differentiate along a SMC pathway when exposed to TGFβ1
(Hirschi et al., 1998). As shown in Fig. S7, addition of TGFβ1 produces
signiﬁcant increases in smooth muscle marker-positive cells at 24 h
that are further increased at 48 h. However, in cultures that were
transfected with Tbx18 expression vector 24 h before addition of
TGFβ1 and examined by immunoﬂuorescence staining at 24 h or 48 h
after exposure to TGFβ1, the appearance of SMC marker-positive cells
was strongly inhibited (Fig. 8E). This was not due to an increase in the
rate of apoptosis of Tbx18 overexpression cells (TUNEL assay, data not
shown), nor was there a signiﬁcant difference found in the rate of cell
proliferation (phospho-Histone H3, data not shown) of Tbx18 over-
expression cells compared to cells that did not overexpress Tbx18.
Moreover, we did not observe expression of SMC markers in the
Tbx18 overexpression cells (Fig. 8F and G). Taken together, the data
described above strongly suggest that Tbx18 is a transcriptional co-
repressor of SRF-CArG box-dependent SMC marker gene expression
that can inhibit SMC differentiation from multipotent mesenchymal
progenitor cells.
Discussion
Development of the coronary vasculature requires reciprocal
signaling interactions between epicardium, myocardium and coronary
vessels. We found that Tbx18 is required for proper formation and
Fig. 6. Coronary vascular casts at E18.5 examined by scanning electron microscopy. (A) Wild type heart showing the left coronary artery (LCA) and its ﬁrst order distributing
branch arteries (L1, L2, etc). (B)–(D) Coronary casts of Tbx18 / hearts showing a range of deviations from the wild type pattern, particularly in the number and size of
branch conduit arteries. (E) and (F) Coronary casts showing lumen diameters of the LCA (m, m′) and ﬁrst order branch arteries (b, b′) from wild type (E) and Tbx18 /
(F) hearts. (G) Morphometric analysis of lumen diameter ratios (b/m) for ﬁrst order branch arteries from ScEM images of coronary casts. Note the signiﬁcant reductions in
lumen diameter ratios in Tbx18 / hearts (n¼6, total branch points analyzed¼69), compared to Tbx18þ /þ hearts (n¼8, total branch points analyzed¼84). * po0.05.
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remodeling of the subepicardial coronary vascular plexus. Since we
observed defects in plexus formation that precede the establishment
of coronary connections to the aorta at E13.5, the early vascular defects
are unlikely to be secondary to alterations in either cardiac output or
general systemic circulation in Tbx18 / embryos. Therefore, we
suggest that defects in coronary vasculogenesis in Tbx18-deﬁcient
hearts are the consequence of altered epicardial cell signaling or cell
fate that results in abnormal differentiation, assembly and remodeling
of coronary endothelial and perivascular cells within the subepicardial
space. Indeed, gene expression analysis at E12.5 showed reduced
levels of VEGF-A, VEGF-B, Endoglin, and Angiopoietin-1 transcripts,
increased expression of Angiopoietin-2, and strong down regulation
of the hedgehog signaling markers Ptch1, Smo and Gli2. Although each
of these factors has been implicated in coronary vessel development
(Tomanek, 2005; Lavine et al., 2006; Ward and Dumont, 2004; Perez-
Pomares and de la Pompa, 2011), the nature of an epicardial control
pathway that regulates their production in the developing heart has
not been identiﬁed.
Tbx18 and development of the epicardium
Tbx18 is strongly expressed in the PE and septum transversum
mesenchyme (Kraus et al., 2001). Despite high levels of Tbx18
expression in PE fromwild type hearts, we found no differences in
the localization, growth or vesiculation of the PE in Tbx18 /
embryos compared to Tbx18þ /þ littermates (not shown). More-
over, our studies of freshly isolated E9.5 PE ex vivo failed to identify
signiﬁcant differences in expression of epicardial markers (WT1,
capsulin, a4-integrin) between wild type and Tbx18-deﬁcient cells
(not shown). Expression of collagens type I, III, and IV as well as
ﬁbronectin and tenascin C in explanted PE also did not signiﬁ-
cantly differ between Tbx18 genotypes (not shown). Formation of
epicardium appeared to initiate properly in Tbx18-mutant mice
and a complete epicardial covering of the heart was present at
E11.5 and at E18.5 (not shown). Our results agree with the
observation reported by Greulich et al. that epicardium of
Tbx18/ hearts is intact at the perinatal stage (Greulich et al.,
2012). However, we identiﬁed a previously undescribed epicardial
phenotype in which the appearance and organization of Tbx18 /
epicardium showed clear differences from that of wild type at
E12.5, the critical time of epicardium-dependent coronary vascu-
logenesis in the subepicardial space. Epicardium covering the
ventricular free walls in Tbx18 / hearts was irregular with small
mound-like distensions and occasional large cyst-like structures
deforming the epicardial surface. These protrusions were asso-
ciated with underlying accumulations of erythroblasts clustered in
structures reminiscent of blood islands. While formation of
blood islands has been reported during coronary vasculogenesis
(Kattan et al., 2004; Tomanek et al., 2006), they are usually
few in number and conﬁned to the atrio-ventricular canal. In
Tbx18 / hearts, ectopic blood island-like structures were greatly
increased in number and distributed over ventricular free walls.
An origin of hematopoietic cells from PE has been previously
reported (Kattan et al., 2004). Since we were unable to detect
β-galactosidase expression from our mutant allele in these
blood island-like structures, their mislocalization and elevated
numbers may be an indirect consequence of a defective signaling
environment in the subepicardium of Tbx18/ hearts. Given
Fig. 7. Altered molecular proﬁle of Tbx18 / hearts. (A) Fold changes of genes associated with vascular development in E12.5 mutant hearts compared with control. Color
codes representing change of mRNA levels relative to control are listed at the bottom of the panel. Actual numbers can be found in Table S2 and S3. (B) and (C) A model for
roles of Tbx18 in coronary vasculogenesis. Bottom panels: a model whereby loss of Tbx18 expression in the epicardium produces a defective coronary plexus. Disruption of
normal epicardial-myocardial signaling interactions (B) in Tbx18 / hearts (C) leads to reduced levels of hedgehog signaling in the myocardium and lower expression levels
of hedgehog target genes including ptch1, Vegfa, and Angpt1. In addition, Wnt and TGF-b pathways are also responsive to loss of Tbx18 function in the heart. The combined
result is failure to form a well-ordered, highly branched coronary vascular plexus at E12.5 (D) and (E). Remodeling of the defective plexus in mutant hearts leads to a mature
network of distributing coronary arteries that are fewer in number, shorter in length and smaller in lumen diameter (D) and (E) with a reduced capacity for coronary blood
ﬂow distribution (E18.5 LCA).
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reports that the PE contains erythroid progenitors (Tomanek et al.,
2006; Wilting et al., 2007), that reduction of VEGF signaling with a
soluble VEGF-R1/R2 chimera (VEGF trap) produced large increases
in subepicardial erythroid cells (Tomanek et al., 2006), together
with an absence of coronary blood ﬂow at E12.5, we favor the idea
that ectopic blood island-like structures arise de novo from PE-
derived cells, yet other possibilities cannot be excluded at this time
(Ratajska et al., 2006). Interestingly, this epicardial phenotype was
observed in the Tbx18-null mice of the 129/C57BL6/J background
but not in that of the NMRI outbred background (Greulich et al.,
2012), suggesting currently unknown genetic modiﬁers that might
interact with Tbx18 to regulate epicardial development.
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(0) group. (E)–(G) C3H10T1/2 cells were transfected with or without the V5-tagged Tbx18 expression vector (Tbx18OE and control, respectively) for 24 h followed by TGF-β1
stimulation for 24 or 48 h. Then cells were ﬁxed and immunostained for V5 (green) plus SM22α (F, red) or SMγA (G, red). The percentage of SM22αþ or SMγAþ cells was
quantiﬁed by scoring 3000 cells in 10 non-overlapping ﬁelds each from 3 independent experiments (E) and shown as mean7standard error of the mean. npo0.05
compared with non-transfected control.
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Tbx18 and development of the coronary vasculature
Coronary endothelial cells appear in the subepicardial space
between E10.5 and E11.5, and are directed to assemble into a
tubular plexus by growth factors, matrix proteins, hypoxia and
proteases within the subepicardium (Olivery and Svensson, 2012).
These vasculogenic factors are produced by both the epicardium
and the bordering myocardium. Tbx18-deﬁcient hearts produce a
malformed subepicardial plexus characterized by an irregular
network of tubular structures of variable sizes that made fewer
connections within the plexus. Tube formation in coronary vessels
is under control of angiogenic growth factors including members
of the VEGF, angiopoietin, Wnt and TGFβ families (Tomanek, 2005,
Ward and Dumont, 2004; Holiﬁeld et al., 2004; Perez-Pomares and
de la Pompa, 2011; Zamora et al., 2007). Each of these growth
factor families is misexpressed in Tbx18 / hearts. Moreover,
Vokes et al. reported that vascular tube formation in avian
embryos requires factors produced by the endoderm, and that a
key endoderm-derived factor that promotes tube formation is
sonic hedgehog (Shh) (Vokes et al., 2004). Lavine et al. reported
that myocardial FGF signaling triggers a wave of Shh activation in
the myocardium of developing mouse hearts that is required for
VEGF-A, -B, and -C expression during coronary development
(Lavine et al., 2006). Our gene expression studies indicated that
Shh signaling is down-regulated in Tbx18-deﬁcient hearts, point-
ing to a key potential pathway by which subepicardial plexus
formation may be deﬁcient in these hearts (Fig. 7). In the later
stage at E18.5, observations from Greulich et al. and us both
indicate that the main coronary arteries and capillary vessels are
developed in the Tbx18 / hearts (Fig. 2C–E and Fig. 6) (Greulich
et al., 2012). Our data further demonstrated that Tbx18 / hearts
exhibited simpliﬁed branching complexity and reduced lumen
diameter ratios of ﬁrst order distributing arteries in the prin-
ciple subepicardial distributing vessels at the perinatal stage
(Fig. 6). Given that the development of coronary stems appeared
unaffected in Tbx18 / mice (Fig. 5B), it is not surprising to see
that hemodynamic effects contribute to vascular remodeling after
connecting to systemic circulation (Lucitti et al., 2007).
Tbx18 and maintaining the progenitor status of epicardial-derived
cells
Expression levels of Tbx18 are rapidly downregulated following
epithelial to mesenchymal transition of the epicardium to generate
EPDC, a critical early step in coronary vessel development.
Our data and those of Greulich et al. (2012) reach a similar
conclusion that Tbx18 may play an important role as a transcrip-
tional corepressor to control the timing of EPDC differentiation
during early steps in coronary vessel development. In particular,
Tbx18 may prevent premature SMC differentiation in epicardium
and EPDC and thereby ensure timely progression of CoSMCs
differentiation and their recruitment onto coronary vessels during
heart development. Our in vitro transcription studies suggest that
the ability of Tbx18 to inhibit premature smooth muscle differ-
entiation may be due to its repressor activity on SRF/myocardin-
CArG-dependent transcription of smooth muscle differentiation
marker genes. Conversely, our model also predicts that conver-
ting the transcription-repressing Tbx18 into a transcription-
activating factor should promote smooth muscle differentiation
through driving the expression of smooth muscle genes. Indeed,
Greulich and colleagues demonstrate premature adoption of
the smooth muscle phenotype by EPDC in a Tbx18VP16 misex-
pression study. Results of our study are in agreement with their
model and further support the notion that Tbx18 maintains the
epicardial progenitor status by repressing smooth muscle gene
expression.
Tbx18, a novel epicardial mutant phenotype
To date, most genes whose loss of function phenotypes produce
epicardial defects exhibit a pronounced thinning of the compact layer
myocardium (Sucov et al., 1994; Kwee et al., 1995; Moore et al., 1999;
Merki et al., 2005; von Gise et al., 2011; Zamora et al., 2007; Acharya
et al., 2012; Lin et al., 2012). These embryos die in utero from cardiac
failure. On the other hand, despite defective EMT inmice with ablation
of Nf1 or PDGF receptors, no obvious myocardium or coronary
network defects were reported (Baek and Tallquist, 2012; Smith
et al., 2011). In contrast, Tbx18 / hearts exhibited defective coronary
vessel patterning from E12.5 and beyond while myocardial wall
thickness and heart weight to body weight ratios were not signiﬁ-
cantly different from wild type at E18.5 (not shown), and an intact
epicardiumwas present from E11.5 to birth. Amendelian ratio of Tbx18
genotypes was found at E18.5, indicating an absence of signiﬁcant
embryonic lethality due to cardiac failure. Death of Tbx18 / mice
within hours after birth precludes a detailed analysis of cardiac
function in Tbx18 mutants. Yet, a reduction in coronary network
structural capacity to conduct blood ﬂow, as described here, may
not compromise cardiac development or baseline cardiac function.
Such defects may only be evident with very high or sustained levels of
cardiac activity or in hearts compromised by coronary disease.
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